| Schedule of Amounts Due from Related Parties |
Amounts due from related parties consisted of the following as of December
31, 2024 and 2023:
| | |
December 31,
2024 | | |
December 31,
2023 | |
| Current | |
| | |
| |
| Aeneas Management Limited | |
$ | - | | |
$ | 961 | |
| Libra Sciences Limited (Note b) | |
| 522,192 | | |
| 521,007 | |
| Allowance for credit loss | |
| (522,192 | ) | |
| (521,007 | ) |
| Total | |
$ | - | | |
$ | 961 | |
|
| Schedule of Amounts Due to Related Parties |
Amounts due to related parties consisted of the following as of December
31, 2024 and 2023:
| | |
December 31,
2024 | | |
December 31,
2023 | |
| Current | |
| | |
| |
| Aeneas Group Limited (Note a) | |
$ | 79,180 | | |
$ | 79,180 | |
| Ian Huen | |
| 464 | | |
| - | |
| | |
$ | 79,644 | | |
$ | 79,180 | |
|
| Schedule of Convertible Notes to a Related Party |
| | |
December 31,
2024 | | |
December 31,
2023 | |
| Convertible notes to a related party - Current | |
| | |
| |
| Jurchen Investment Corporation (Note 15) | |
$ | 3,238,500 | | |
$ | - | |
| | |
| | | |
| | |
| Convertible notes to a related party - Non-current | |
| | | |
| | |
| Jurchen Investment Corporation (Note 15) | |
$ | - | | |
$ | 3,058,500 | |
|
| Schedule of Related Party Transactions |
Related party transactions consisted of the following
for the years ended December 31, 2024, 2023 and 2022:
| | |
Year ended
December 31,
2024 | | |
Year ended
December 31,
2023 | | |
Year ended
December 31,
2022 | |
| Loan from related parties (Note a) | |
| | |
| | |
| |
| - Aeneas Group Limited | |
$ | - | | |
$ | 2,500,000 | | |
$ | 500,000 | |
| | |
| | | |
| | | |
| | |
| Issuance of Convertible Note to related parties (Note 15) | |
| | | |
| | | |
| | |
| - Jurchen Investment Corporation | |
$ | - | | |
$ | 3,000,000 | | |
$ | - | |
| - Aenco Technologies Ltd | |
$ | - | | |
$ | - | | |
$ | 3,000,000 | |
| | |
| | | |
| | | |
| | |
| Settlement of loan from a related party through issuance of Convertible Note (Note 15) | |
| | | |
| | | |
| | |
| - Aeneas Group Limited | |
$ | - | | |
$ | 3,000,000 | | |
$ | - | |
| | |
| | | |
| | | |
| | |
| Interest expenses (Note a and Note 15) | |
| | | |
| | | |
| | |
| - Aeneas Group Limited | |
$ | - | | |
$ | 71,123 | | |
$ | 8,110 | |
| - Jurchen Investment Corporation | |
$ | 180,000 | | |
$ | 58,500 | | |
$ | - | |
| - Aenco Technologies Ltd | |
$ | - | | |
$ | (13,234 | ) | |
$ | 13,234 | |
| | |
| | | |
| | | |
| | |
| Loan to related parties (Note b) | |
| | | |
| | | |
| | |
| - Libra Sciences Limited | |
$ | - | | |
$ | 92,459 | | |
$ | 330,341 | |
| | |
| | | |
| | | |
| | |
| Loan repayment and interest received from a related party (Note b) | |
| | | |
| | | |
| | |
| - Talem Medical Group Limited | |
$ | - | | |
$ | 611,641 | | |
$ | 2,962,153 | |
| | |
| | | |
| | | |
| | |
| Interest income (Note b) | |
| | | |
| | | |
| | |
| - Talem Medical Group Limited | |
$ | - | | |
$ | 4,637 | | |
$ | 164,600 | |
| - Libra Sciences Limited | |
$ | - | | |
$ | 8,963 | | |
$ | 14,232 | |
| | |
| | | |
| | | |
| | |
| Consultant, secondment, management and administrative services fees (Note c) | |
| | | |
| | | |
| | |
| - CGY Investments Limited | |
$ | - | | |
$ | 153,640 | | |
$ | 268,102 | |
| - ACC Medical Limited | |
$ | - | | |
$ | 138,768 | | |
$ | 209,626 | |
| | |
| | | |
| | | |
| | |
| Administrative management services (Note d) | |
| | | |
| | | |
| | |
| - Libra Sciences Limited | |
$ | - | | |
$ | 9,615 | | |
$ | 38,462 | |
| | |
| | | |
| | | |
| | |
| Healthcare services income | |
| | | |
| | | |
| | |
| - Aeneas Management Limited | |
$ | - | | |
$ | 961 | | |
$ | 1,282 | |
|